Shopping Cart
Your shopping cart is empty
Login
Register
Forgot Password?
Home
Products
Suppliers
News
Promotions
Helpdesk
Vacature
About Bio-Connect
Our Divisions
Our Team
Quality and Environmental Management
Meet us at
Contact
COVID-19 Reagents
Antibodies
Arrays / Slides
Assays
Body Products
(Cell) Culture
Chemicals
DNA / RNA / Vectors
Expression
Genome Editing and Engineering
Labware / Accessories
Lysates / Extracts
Molecular Biology
Proteins / Signaling Molecules
Technique Specific Products
Targets
Join us
Stock sale
(Junior) Marketeer
Medewerker Customer Service
Description
Catalog number
CAS No.
Clone ID
Order information
Order online, fax your order to +31 (0)26 326 4451 or e-mail your order to
orders(at)bio-connect.nl
.
Need another amount?
Contact us
to find out the possibilities.
Can't find what you are looking for?
Bio-Connect Services specialises in assisting you in finding all the products you need for your research. Check out our video to see how it works or go to
www.bio-connectservices.com/how-it-works
.
News
Work with HUABIO antibodies
High quality mRNAs by OZ Biosciences
Process specific assay development
Cytokines and growth factors by Sino Biological
Discover NEW InVivoSIM™ biosimilar antibodies
Neuroinflammation monoclonal antibodies
MCE new small molecules
AUMsilence: FANA antisense oligonucleotides
mRNA vaccine-induced antibody profiles against SARS-CoV-2 variants
Don’t have time to grow and purify your antibody from a hybridoma?
Vorige
Volgende
InVivoMab anti-mouse OX40L (CD134L)
Catalog number:
BE0033-1_100mg
Brand:
Bio X Cell
Packing:
100 mg
Other sizes:
1 mg
5 mg
25 mg
50 mg
Price:
€ 2583.00
Expected delivery time:
7 days
Quantity:
Spin Up
Spin Down
General
References
Product specifications for - InVivoMab anti-mouse OX40L (CD134L)
Promotion:
Promotion:
The price displayed is only for academic or non-profit organizations. Please
contact our helpdesk
for regular prices.
Overview:
Product group:
Antibodies
Category:
Primary Antibodies
Application:
Neutralisation/Blocking
Species:
Mouse
Host:
Rat
Clonality:
Monoclonal
Isotype:
IgG2b Kappa
Properties:
Molecular weight:
150 kDa
Datasheet:
Datasheet
Research Use Only
UNSPSC:
12352203
Concentration:
2-10 mg/ml
Scientific information:
Clone ID:
RM134L
Related products:
Related products:
Recommended Isotype Control(s):
InVivoMab rat IgG2b isotype control (BE0090)
Recommended Dilution Buffer:
InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information:
Synonyms:
RM134L; BE0033-1; OX40 Ligand / OX40L; TNFSF4; TXGP1; OX4OL; OX-40L; GP34; CD252; CD134L; tumor necrosis factor ligand superfamily member 4; tax-transcriptionally activated glycoprotein 1 (34kD); glycoprotein Gp34; TAX transcriptionally-activated glycoprotein 1; OX40L; OX40 antigen ligand; CD134 ligand; tumor necrosis factor (ligand) superfamily, member 4; BioXCell
Gattringer M, Baranyi U, Pilat N, et al. Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen. Clin Exp Allergy. 2016;46(2):354-64.
Read more
Welten SP, Redeker A, Franken KL, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. Elife. 2015;4
Read more
Baeyens A, Saadoun D, Billiard F, et al. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context. J Immunol. 2015;194(3):999-1010.
Read more
Xin L, Jiang TT, Chaturvedi V, et al. Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2. Proc Natl Acad Sci USA. 2014;111(29):10672-7.
Read more
Mahmud SA, Manlove LS, Schmitz HM, et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol. 2014;15(5):473-81.
Read more
Leyva-castillo JM, Hener P, Michea P, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun. 2013;4:2847.
Read more
Hong J, Yeom HJ, Lee E, et al. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents. Transpl Immunol. 2013;28(2-3):86-92.
Read more
Kurche JS, Burchill MA, Sanchez PJ, Haluszczak C, Kedl RM. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J Immunol. 2010;185(4):2106-15.
Read more
See All